Depression is a common mental health condition characterised by persistent feelings of sadness, hopelessness, and a loss of interest in daily activities. It affects mood, thoughts, and physical wellbeing, making it difficult to function at work, school, or home. In Australia, depression is one of the most prevalent mental health conditions, affecting millions of people across all age groups. If left untreated, depression can significantly impact quality of life and may lead to serious complications.
Various forms of depression exist, including major depressive disorder, persistent depressive disorder (dysthymia), postpartum depression, and seasonal affective disorder. Each type presents differently and may require tailored treatment approaches. Understanding which type you're experiencing helps determine the most effective medication and therapy combination for your situation.
Common antidepressants prescribed in Australia include selective serotonin reuptake inhibitors (SSRIs) such as sertraline, citalopram, and fluoxetine. Serotonin-noradrenaline reuptake inhibitors (SNRIs) like venlafaxine and duloxetine are also widely available. Tricyclic antidepressants and other options may be recommended depending on individual circumstances. These medications work by adjusting brain chemistry to improve mood and emotional regulation.
Anxiety disorders involve excessive worry and fear that interferes with daily life. Unlike normal stress or nervousness, clinical anxiety persists over extended periods and often worsens without treatment. Common anxiety disorders include generalised anxiety disorder, panic disorder, social anxiety, and specific phobias. Many Australians experience anxiety at some point, and effective treatments are readily available through pharmacies and healthcare providers.
Anxiety can manifest through physical symptoms like rapid heartbeat, sweating, and trembling, alongside psychological effects such as racing thoughts and difficulty concentrating. These symptoms may prevent people from working, socialising, or pursuing activities they enjoy. Early identification and treatment significantly improve outcomes and quality of life.
SSRIs and SNRIs commonly prescribed for anxiety include sertraline, paroxetine, and venlafaxine. Benzodiazepines like diazepam and alprazolam may be recommended for short-term relief, though they're typically not used long-term due to dependency risks. Beta-blockers can help manage physical symptoms. Combined medication and therapy approaches often yield the best results for anxiety management.
Bipolar disorder is characterised by extreme mood fluctuations between depressive episodes and manic or hypomanic phases. During manic periods, individuals experience elevated mood, increased energy, and impulsive behaviour. Depressive phases involve the opposite—deep sadness and low motivation. This disorder significantly impacts relationships, work, and overall functioning, making proper medication management essential for stability and wellbeing.
Manic episodes may include decreased need for sleep, excessive talking, and risky decision-making. Depressive episodes follow, bringing prolonged sadness and loss of interest in activities. Mood episodes can last days, weeks, or months, creating unpredictability in daily life. Professional diagnosis is crucial to distinguish bipolar disorder from other mental health conditions.
Mood stabilisers are the cornerstone of bipolar treatment. Lithium remains a gold-standard medication, requiring regular blood tests to maintain safe levels. Anticonvulsants such as valproate and lamotrigine are also commonly prescribed. Atypical antipsychotics like quetiapine, olanzapine, and aripiprazole help manage both manic and depressive symptoms. Finding the right medication combination often takes time and patience.
Psychotic disorders involve losing touch with reality through hallucinations (seeing or hearing things others don't) or delusions (false beliefs). Schizophrenia is the most common psychotic disorder, affecting how people think, feel, and perceive the world. These conditions can be frightening and isolating, but medication and support significantly improve outcomes. Early intervention substantially increases the likelihood of recovery and independent living.
Positive symptoms include hallucinations and delusions, while negative symptoms involve reduced emotional expression and motivation. Cognitive difficulties affecting memory and concentration are also common. Diagnosis requires professional assessment from psychiatrists or mental health specialists. Recognising symptoms early allows for faster treatment initiation and better long-term prognosis.
Antipsychotic medications are the primary treatment, with first-generation options like haloperidol alongside newer second-generation antipsychotics such as risperidone, olanzapine, quetiapine, and aripiprazole. Second-generation antipsychotics are often preferred due to fewer side effects. Injectable long-acting formulations are available for people who struggle with medication adherence. Combination approaches incorporating medication and psychological support yield optimal results.
OCD involves intrusive, unwanted thoughts (obsessions) and repetitive behaviours or mental acts (compulsions) performed to reduce anxiety. People with OCD recognise their thoughts are irrational but feel unable to stop them. This condition can consume hours daily and significantly impair work, relationships, and quality of life. Treatment combining medication and therapy effectively reduces symptoms and restores functioning.
Obsessions may involve fears of contamination, harm, or needing things "just right." Compulsions include excessive cleaning, checking, counting, or organising. These rituals provide temporary relief but ultimately reinforce the cycle. OCD is not about being neat or organised—it's a distressing condition requiring professional intervention and support.
SSRIs are first-line medications, with higher doses often needed compared to depression treatment. Sertraline, fluoxetine, and paroxetine are commonly prescribed in Australia. Response may take 8-12 weeks. Cognitive-behavioural therapy, particularly exposure and response prevention, is equally important alongside medication. Some individuals benefit from augmentation strategies with additional medications recommended by their psychiatrist.
PTSD develops following exposure to traumatic events such as accidents, violence, natural disasters, or warfare. People with PTSD experience intrusive memories, nightmares, hypervigilance, and avoidance of trauma reminders. Symptoms can emerge immediately or develop months later. In Australia, PTSD affects military personnel, emergency workers, trauma survivors, and others. Evidence-based treatment significantly reduces symptoms and improves daily functioning.
Re-experiencing symptoms include flashbacks and nightmares where individuals feel the trauma is happening again. Avoidance involves steering clear of places, people, or activities associated with trauma. Negative mood changes and hyperarousal (being easily startled, irritable) are also characteristic. Severity varies—some people manage with support, whilst others require intensive treatment.
SSRIs including sertraline and paroxetine are approved specifically for PTSD treatment in Australia. These medications reduce intrusive thoughts and emotional numbness. Trauma-focused cognitive-behavioural therapy is equally important, helping people process trauma memories and reduce avoidance. Combination treatment of medication and therapy produces the best outcomes. Professional mental health practitioners can assess severity and recommend appropriate interventions tailored to individual needs.
